131
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Mechanism of gene transfection by polyamidoamine (PAMAM) dendrimers modified with ornithine residues

, , , &
Pages 770-780 | Received 13 Jul 2010, Accepted 23 Feb 2011, Published online: 04 Apr 2011
 

Abstract

The aim of this study was to prepare and investigate the mechanism of uptake of the dendriplexes prepared with ornithine-conjugated polyamidoamine (PAMAM) G4 dendrimers. Ornithine-conjugated PAMAMG4 dendrimers were prepared by Fmoc synthesis. A comparative transfection study in NCI H157G cells and polyamine transport-deficient cell line NCI H157R was performed to confirm the role of the polyamine transporter system (PAT) in the dendriplex uptake. Transfection efficiency significantly increased with increase in generation number and extent of ornithine conjugation. Transfection efficiency of the PAMAMG4-ORN60 dendrimers significantly decreased in presence of excess of ornithine (P < 0.05) and paraquat (P < 0.01) but not of PAMAMG4 dendrimers. Transfection efficiency of PAMAMG4-ORN60 was significantly low in NCI H157R (31.66 ± 3.95%, RFU: 17.87 ± 1.34) as compared to NCI H157G cell line (63.07 ± 6.8%, relative fluorescence units (RFU): 23.28 ± 0.66). Results indicate the role of PAT in addition to charge-mediated endocytosis in the internalization of ornithine-conjugated PAMAMG4 dendrimers. Cytotoxicity analysis (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay) in human embryonic kidney cell line (HEK) 293T cells showed that the dendriplexes were non-toxic at N/P 10.

Acknowledgments

The authors are thankful to Dr. Robert A. Casero Jr., School of Medicine, Johns Hopkins University, Baltimore, MD for providing NCI H157G and NCI H157R cells lines. The authors also thank Mr. Andrew Ramirez, Multimedia Designer, ILR College of Pharmacy, Texas A&M HSC for technical help in the preparation of the manuscript.

Declaration of interest

The authors declare no conflict of interest. This work was partly supported by a grant from National Institutes of Health (NIH R15 CA121980-01) to S.P.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.